- CureToday.com
- OncLive.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
Matthew Fowler | Authors
Articles
Genomic Test Does Not Increase Active Surveillance Acceptance for Treating Favorable-Risk Prostate Cancer
May 14, 2021
The results from a trial evaluating the Genomic Prostate Score did not find an increase in active surveillance acceptance amongst a population of predominantly Black men with favorable-risk prostate cancer.
Platinum Sensitivity, Genomic Markers Associated With Rucaparib Response for High-Grade Ovarian Carcinoma
May 13, 2021
Investigators assessed a 2-part study to investigate the prognostic impact of certain clinical features and genomic markers for rucaparib in treating patients with relapsed high-grade ovarian carcinoma.
Electron Intraoperative Radiotherapy Associated With Increased IBTR Rates for Early-Stage Breast Cancer
May 12, 2021
The long-term equivalence trial examined the rates of ipsilateral breast tumor recurrence for patients receiving electron intraoperative radiotherapy and whole-breast irradiation at 5-, 10-, and 15-year follow-up times.
Improved Overall Survival Observed With Lenvatinib for Patients With Thyroid Cancer and Lung Metastases
May 11, 2021
Investigators observed a survival benefit for patients receiving lenvatinib who had radioiodine-refractory differentiated thyroid cancer with lung metastases of 1 cm or greater.
Oncology Peer Review On-The-Go: A Critical Interval to Delay Progression of Prostate Cancer
May 11, 2021
E. David Crawford, MD, spoke about the use of transitional disease and other redefined disease states in prostate cancer, while Rana McKay, MD emphasized the need for clinical trials to validate current treatments and practices.
CancerNetwork®’s Week in Review: May 10, 2021
May 10, 2021
Look back at some of the important news and notes from last week in the world of oncology, featuring an FDA approval and a Journal ONCOLOGY® article on prostate cancer disease states.
Caloric and Nutrient Restrictions Positively Impacted Response for Overweight Patients With B-cell ALL
May 09, 2021
Reducing caloric and nutrient intake for patients who were overweight or obese and undergoing induction for B-cell acute lymphoblastic leukemia was feasible and improved patient response, according to an early-phase trial.
Real-World Data Suggest Systemic High-Dose and Intrathecal MTX Lower CNS Relapse Incidence for DLBCL
May 07, 2021
The 3-year follow-up analysis of 4 treatment groups who received CNS prophylaxis found a decreased incidence of CNS relapse for patients with high-risk diffuse large B-cell lymphoma, although the data were not statistically significant.
Subgroup Analyses of KATHERINE Trial Promote T-DM1 Use in High-Risk Groups
May 07, 2021
The KATHERINE trial found a clinical benefit without increasing the risk of CNS recurrence for patients with HER2-positive early breast cancer treated with T-DM1.
Single-Agent Carboplatin Produced Worse Survival Versus Carboplatin Plus Paclitaxel for Adult Women With Ovarian Cancer
May 05, 2021
Research focusing on first-line single-agent carboplatin was terminated due to an independent data monitoring committee’s recommendation after worse survival outcomes were observed in adult patients with ovarian cancer.